Subtotal $0.00
Breathe Hospital, Khammam is committed to delivering advanced chest care, critical care, and multispecialty healthcare with compassion and clinical excellence.
Tuberculosis remains a preventable and curable infectious disease when managed with accurate diagnostic precision and adherence to standardized therapy. At Breathe Hospital, Khammam, our clinical protocols are strictly aligned with the Central TB Division, Ministry of Health & Family Welfare (Government of India) guidelines under the National Tuberculosis Elimination Program (NTEP).
Whether addressing newly diagnosed Drug-Sensitive TB (DS-TB) or complex Drug-Resistant cases (MDR/RR-TB), our pulmonology team in Khammam delivers evidence-based, compassionate, and holistic care.
Under current NTEP standards, empirical treatment without diagnostic confirmation is strongly discouraged. At Breathe Hospital, Khammam, we employ upfront Molecular Diagnostics (NAAT / CBNAAT / Truenat) for all presumptive TB patients to ensure rapid identification and early detection of Rifampicin resistance.
As per Government guidelines, the standard treatment for new Drug-Sensitive Pulmonary Tuberculosis consists of a 6-month daily regimen using Fixed Dose Combinations (FDCs) categorized according to patient body weight bands. Treatment is divided into two distinct phases:
| Phase | Duration | Medications Included | NTEP Standard FDC Formulation | Clinical Goal |
|---|---|---|---|---|
| Intensive Phase (IP) | 2 Months (56 Doses) | Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E) | 4-FDC (HRZE) Daily Dose | Rapid bacteriological clearance, symptom resolution & preventing transmission. |
| Continuation Phase (CP) | 4 Months (112 Doses) | Isoniazid (H), Rifampicin (R), Ethambutol (E) | 3-FDC (HRE) Daily Dose | Eradication of dormant bacilli & prevention of relapse/recurrence. |
At Breathe Hospital, Khammam, daily drug administration is strictly calculated across standard NTEP weight bands (25-34 kg, 35-49 kg, 50-64 kg, 65-75 kg, and >75 kg). Dosage adjustments are continuously updated whenever a patient experiences weight gain exceeding 5 kg during monthly clinical evaluations.
Drug-Resistant Tuberculosis demands expert pulmonology supervision. Following recent government updates, shorter all-oral regimens such as the BPaLM regimen (comprising Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin) are implemented for eligible MDR/RR-TB patients under close clinical monitoring.
At Breathe Hospital, Khammam, Drug Resistance Testing (DRT) is conducted upfront for all culture-positive or high-risk individuals. Patients receive structured counseling regarding medication adherence, potential side-effect mitigation, and regular organ toxicity monitoring (including baseline and monthly ECGs, LFTs, and vision screening).
In accordance with national post-TB guidelines, we offer structured pulmonary rehabilitation involving Pursed-Lip Breathing, Diaphragmatic Exercises, and Inspiratory Muscle Training to restore lung function post-infection.
Malnutrition severely impairs immune recovery. Our clinical dietitians assess BMI and dietary intake, assisting patients with enrollment into government financial support programs like Ni-kshay Poshan Yojana.
We guide family members on household airborne infection control (AIC), adequate room ventilation, mask usage during infectious phases, and Tuberculosis Preventive Treatment (TPT) for household contacts.
If you or a loved one have been experiencing a cough for more than 2 weeks, low-grade fever, unexplained weight loss, or night sweats, consult our senior pulmonology team at Breathe Hospital, Khammam today for comprehensive evaluation and government-certified care.